The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nadroparin Calcium Injection Market Research Report 2024

Global Nadroparin Calcium Injection Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1742816

No of Pages : 90

Ask Your Query

Synopsis
Dronaparin Calcium Injection is an anticoagulant drug, mainly used for the prevention and treatment of diseases related to the blood circulation system such as thrombosis and venous thromboembolism. Its main ingredient is low molecular weight heparin calcium (Enoxaparin Calcium).

Global Nadroparin Calcium Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nadroparin Calcium Injection market research.

Key manufacturers engaged in the Nadroparin Calcium Injection industry include Aspen Pharmacare, Tianjin Chasesun Pharmaceutical Co., Ltd., Changzhou Qianhong Biopharma Co., Ltd., Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Shenzhen Sciprogen Bio-pharmaceutical Co., Ltd., Zhaoke Pharmaceutical (Hefei) Co., Ltd. and Tianjin Biochemical Pharmaceutical Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Nadroparin Calcium Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nadroparin Calcium Injection market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nadroparin Calcium Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Aspen Pharmacare
  • Tianjin Chasesun Pharmaceutical Co., Ltd.
  • Changzhou Qianhong Biopharma Co., Ltd.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
  • Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
  • Shenzhen Sciprogen Bio-pharmaceutical Co., Ltd.
  • Zhaoke Pharmaceutical (Hefei) Co., Ltd.
  • Tianjin Biochemical Pharmaceutical Co., Ltd.

Segment by Type

  • 0.6ml:6150AXaIU
  • 0.4ml:4100 AXaIU
  • 0.3ml:3075AXaIU

Segment by Application

  • Hospital
  • Nursing Facility
  • Home Care
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Nadroparin Calcium Injection report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

List of Tables
Table 1. Global Nadroparin Calcium Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Nadroparin Calcium Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Nadroparin Calcium Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nadroparin Calcium Injection Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Nadroparin Calcium Injection Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Nadroparin Calcium Injection Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Nadroparin Calcium Injection Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Nadroparin Calcium Injection Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Nadroparin Calcium Injection, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Nadroparin Calcium Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nadroparin Calcium Injection, Product Type & Application
Table 12. Global Key Manufacturers of Nadroparin Calcium Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nadroparin Calcium Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nadroparin Calcium Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nadroparin Calcium Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nadroparin Calcium Injection Sales by Region (2018-2023) & (K Units)
Table 18. Global Nadroparin Calcium Injection Sales Market Share by Region (2018-2023)
Table 19. Global Nadroparin Calcium Injection Sales by Region (2024-2029) & (K Units)
Table 20. Global Nadroparin Calcium Injection Sales Market Share by Region (2024-2029)
Table 21. Global Nadroparin Calcium Injection Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Nadroparin Calcium Injection Revenue Market Share by Region (2018-2023)
Table 23. Global Nadroparin Calcium Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nadroparin Calcium Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Nadroparin Calcium Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nadroparin Calcium Injection Sales by Country (2018-2023) & (K Units)
Table 27. North America Nadroparin Calcium Injection Sales by Country (2024-2029) & (K Units)
Table 28. North America Nadroparin Calcium Injection Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Nadroparin Calcium Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nadroparin Calcium Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nadroparin Calcium Injection Sales by Country (2018-2023) & (K Units)
Table 32. Europe Nadroparin Calcium Injection Sales by Country (2024-2029) & (K Units)
Table 33. Europe Nadroparin Calcium Injection Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Nadroparin Calcium Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nadroparin Calcium Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nadroparin Calcium Injection Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Nadroparin Calcium Injection Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Nadroparin Calcium Injection Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Nadroparin Calcium Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nadroparin Calcium Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nadroparin Calcium Injection Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Nadroparin Calcium Injection Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Nadroparin Calcium Injection Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Nadroparin Calcium Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nadroparin Calcium Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nadroparin Calcium Injection Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Nadroparin Calcium Injection Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Nadroparin Calcium Injection Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Nadroparin Calcium Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nadroparin Calcium Injection Sales (K Units) by Type (2018-2023)
Table 51. Global Nadroparin Calcium Injection Sales (K Units) by Type (2024-2029)
Table 52. Global Nadroparin Calcium Injection Sales Market Share by Type (2018-2023)
Table 53. Global Nadroparin Calcium Injection Sales Market Share by Type (2024-2029)
Table 54. Global Nadroparin Calcium Injection Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Nadroparin Calcium Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nadroparin Calcium Injection Revenue Market Share by Type (2018-2023)
Table 57. Global Nadroparin Calcium Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Nadroparin Calcium Injection Price (US$/Unit) by Type (2018-2023)
Table 59. Global Nadroparin Calcium Injection Price (US$/Unit) by Type (2024-2029)
Table 60. Global Nadroparin Calcium Injection Sales (K Units) by Application (2018-2023)
Table 61. Global Nadroparin Calcium Injection Sales (K Units) by Application (2024-2029)
Table 62. Global Nadroparin Calcium Injection Sales Market Share by Application (2018-2023)
Table 63. Global Nadroparin Calcium Injection Sales Market Share by Application (2024-2029)
Table 64. Global Nadroparin Calcium Injection Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Nadroparin Calcium Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nadroparin Calcium Injection Revenue Market Share by Application (2018-2023)
Table 67. Global Nadroparin Calcium Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Nadroparin Calcium Injection Price (US$/Unit) by Application (2018-2023)
Table 69. Global Nadroparin Calcium Injection Price (US$/Unit) by Application (2024-2029)
Table 70. Aspen Pharmacare Corporation Information
Table 71. Aspen Pharmacare Description and Business Overview
Table 72. Aspen Pharmacare Nadroparin Calcium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Aspen Pharmacare Nadroparin Calcium Injection Product
Table 74. Aspen Pharmacare Recent Developments/Updates
Table 75. Tianjin Chasesun Pharmaceutical Co., Ltd. Corporation Information
Table 76. Tianjin Chasesun Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Tianjin Chasesun Pharmaceutical Co., Ltd. Nadroparin Calcium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Tianjin Chasesun Pharmaceutical Co., Ltd. Nadroparin Calcium Injection Product
Table 79. Tianjin Chasesun Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Changzhou Qianhong Biopharma Co., Ltd. Corporation Information
Table 81. Changzhou Qianhong Biopharma Co., Ltd. Description and Business Overview
Table 82. Changzhou Qianhong Biopharma Co., Ltd. Nadroparin Calcium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Changzhou Qianhong Biopharma Co., Ltd. Nadroparin Calcium Injection Product
Table 84. Changzhou Qianhong Biopharma Co., Ltd. Recent Developments/Updates
Table 85. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Corporation Information
Table 86. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Nadroparin Calcium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Nadroparin Calcium Injection Product
Table 89. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Corporation Information
Table 91. Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Nadroparin Calcium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Nadroparin Calcium Injection Product
Table 94. Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Shenzhen Sciprogen Bio-pharmaceutical Co., Ltd. Corporation Information
Table 96. Shenzhen Sciprogen Bio-pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Shenzhen Sciprogen Bio-pharmaceutical Co., Ltd. Nadroparin Calcium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Shenzhen Sciprogen Bio-pharmaceutical Co., Ltd. Nadroparin Calcium Injection Product
Table 99. Shenzhen Sciprogen Bio-pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Zhaoke Pharmaceutical (Hefei) Co., Ltd. Corporation Information
Table 101. Zhaoke Pharmaceutical (Hefei) Co., Ltd. Description and Business Overview
Table 102. Zhaoke Pharmaceutical (Hefei) Co., Ltd. Nadroparin Calcium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Zhaoke Pharmaceutical (Hefei) Co., Ltd. Nadroparin Calcium Injection Product
Table 104. Zhaoke Pharmaceutical (Hefei) Co., Ltd. Recent Developments/Updates
Table 105. Tianjin Biochemical Pharmaceutical Co., Ltd. Corporation Information
Table 106. Tianjin Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. Tianjin Biochemical Pharmaceutical Co., Ltd. Nadroparin Calcium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Tianjin Biochemical Pharmaceutical Co., Ltd. Nadroparin Calcium Injection Product
Table 109. Tianjin Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Nadroparin Calcium Injection Distributors List
Table 113. Nadroparin Calcium Injection Customers List
Table 114. Nadroparin Calcium Injection Market Trends
Table 115. Nadroparin Calcium Injection Market Drivers
Table 116. Nadroparin Calcium Injection Market Challenges
Table 117. Nadroparin Calcium Injection Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nadroparin Calcium Injection
Figure 2. Global Nadroparin Calcium Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Nadroparin Calcium Injection Market Share by Type in 2022 & 2029
Figure 4. 0.6ml:6150AXaIU Product Picture
Figure 5. 0.4ml:4100 AXaIU Product Picture
Figure 6. 0.3ml:3075AXaIU Product Picture
Figure 7. Global Nadroparin Calcium Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Nadroparin Calcium Injection Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Nursing Facility
Figure 11. Home Care
Figure 12. Others
Figure 13. Global Nadroparin Calcium Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Nadroparin Calcium Injection Market Size (2018-2029) & (US$ Million)
Figure 15. Global Nadroparin Calcium Injection Sales (2018-2029) & (K Units)
Figure 16. Global Nadroparin Calcium Injection Average Price (US$/Unit) & (2018-2029)
Figure 17. Nadroparin Calcium Injection Report Years Considered
Figure 18. Nadroparin Calcium Injection Sales Share by Manufacturers in 2022
Figure 19. Global Nadroparin Calcium Injection Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Nadroparin Calcium Injection Players: Market Share by Revenue in 2022
Figure 21. Nadroparin Calcium Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Nadroparin Calcium Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Nadroparin Calcium Injection Sales Market Share by Country (2018-2029)
Figure 24. North America Nadroparin Calcium Injection Revenue Market Share by Country (2018-2029)
Figure 25. United States Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Nadroparin Calcium Injection Sales Market Share by Country (2018-2029)
Figure 28. Europe Nadroparin Calcium Injection Revenue Market Share by Country (2018-2029)
Figure 29. Germany Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Nadroparin Calcium Injection Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Nadroparin Calcium Injection Revenue Market Share by Region (2018-2029)
Figure 36. China Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Nadroparin Calcium Injection Sales Market Share by Country (2018-2029)
Figure 44. Latin America Nadroparin Calcium Injection Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Nadroparin Calcium Injection Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Nadroparin Calcium Injection Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Nadroparin Calcium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Nadroparin Calcium Injection by Type (2018-2029)
Figure 54. Global Revenue Market Share of Nadroparin Calcium Injection by Type (2018-2029)
Figure 55. Global Nadroparin Calcium Injection Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Nadroparin Calcium Injection by Application (2018-2029)
Figure 57. Global Revenue Market Share of Nadroparin Calcium Injection by Application (2018-2029)
Figure 58. Global Nadroparin Calcium Injection Price (US$/Unit) by Application (2018-2029)
Figure 59. Nadroparin Calcium Injection Value Chain
Figure 60. Nadroparin Calcium Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock